Best percent change in tumor burden by disease compartment as assessed by IEAC. The best percent change in tumor burden is shown for nodal or extranodal lesions (A), skin lesions (B), and peripheral blood (C) in patients treated with valemetostat. The dashed line indicates a 50% reduction in tumor burden from baseline.